BiondVax Pharmaceuticals - 48 Year Dividend Yield History | BVXV

Historical dividend payout and yield for BiondVax Pharmaceuticals (BVXV) since 1971. The current TTM dividend payout for BiondVax Pharmaceuticals (BVXV) as of February 21, 2019 is $0.00. The current dividend yield for BiondVax Pharmaceuticals as of February 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.036B $0.000B
BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company. The company's product includes Multimeric-001 universal flu vaccine which provides multi-season and multi-strain protection against human influenza virus strains. BiondVax Pharmaceuticals Ltd. is based in Ness Ziona, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29